NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Jefferies Global Healthcare ...

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company ...

Ph.D., will provide a corporate update and engage in one-on-one investor meetings at the Jefferies Global Healthcare Conference from June 3-5, 2025, in New York City, with a presentation scheduled ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on ...

I-Mab will present clinical updates on givastomig at the Jefferies Global Healthcare Conference and share new data at ESMO 2025. I-Mab, a U.S.-based biotech company specializing in precision ...

today announced that Chief Financial Officer Sam Eldessouky is scheduled to participate in the 2025 Jefferies Global Healthcare Conference in New York City on June 4, 2025, at 7:35 a.m. ET.

Corporate overview Presentation Date: Thursday, June 5, 2025 Presentation Time: 11:05 a.m. ET Webcast: Click Here About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 3-5, 2025, in New York, New York. Management will participate in a fireside chat on Wednesday ...

today announced that company management will present at the Jefferies Global Healthcare Conference 2025 in New York on Tuesday, June 4 at 11:40 a.m. ET. Live and replay webcasts may be accessed ...

Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and ...